Compare Cassava Sciences Inc (FLNA) vs Riot Platforms Inc (RIOT) Price & Performance

FLNA trades at $0.8136, down 0.26% today, with a bearish technical signal from moving averages but neutral oscillators. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates in recent quarters. Recent positive news includes FDA lifting a clinical hold on its epilepsy drug, enabling Phase 2a studies.

The outlook remains high-risk due to persistent negative cash flows and lack of revenue, but analyst consensus is bullish with 67% buy ratings. Key risks include clinical trial execution and funding needs, while the FDA decision provides a potential catalyst for long-term investors focused on biotech turnaround stories.

RIOT stock trades at $16.84, down 9.17% in the past 24 hours amid bearish technical signals. The company shows concerning fundamentals with a net income margin of -196.28% and negative cash flow from operations of -$573 million in 2025. However, analyst sentiment remains overwhelmingly positive with 18 buy ratings and a consensus price target of $31.64, representing 88% upside potential. Recent strategic shifts toward AI data center operations with $9.8 billion in contracted lease revenue through 2048 provide long-term growth catalysts.

The outlook remains polarized between strong analyst optimism and challenging financial performance. Investment opportunity exists in RIOT's strategic pivot to AI infrastructure with secured long-term revenue streams, but substantial execution risks persist given current profitability challenges and negative cash flow generation. Stock investors face volatility from both Bitcoin price sensitivity and the company's transition to new business models.